Projects per year
Personal profile
Education
- 2010 Ph.D., National Cheng-Kung University, Taiwan
- 2004 M.S., Chang-Gung University, Taiwan
- 2002 B.S., Kaohsiung Medical University, Taiwan
Experience
- 2024.02-2024.03 Acting Director, Graduate Institute of Biomedical Informatics, Taipei Medical University
- 2022- Professor, International Master Program in Medical Neuroscience, Taipei Medical University
- 2021- Vice Dean, College of Medical Science and Technology, Taipei Medical University
- 2020- Professor, The Ph.D. Program for Neural Regenerative Medicine, Taipei Medical University
- 2017-2020 Associate Professor, The Ph.D. Program for Neural Regenerative Medicine, Taipei Medical University
- 2013-2017 Assistant Professor,The Ph.D. Program for Neural Regenerative Medicine, Taipei Medical University
- 2011-2013 Postdoctoral Fellow, National Institute on Drug Abuse, NIH, U.S.A.
- 2010-2011 Postdoctoral Fellow, National Cheng-Kung University, Tainan, Taiwan
- 2009 Visiting Scholar, National Institute on Drug Abuse, NIH, , U.S.A
- 2004 Research Assistant, Chang-Gung University, Taiwan
Awards
- 2013 National Institutes of Health, Fellows Award for Research Excellence (FARE) 2013 winner
- 2010 National Cheng Kung University, Excellent Research Award
- 2009 The 17th International Symposium on Recent Advances in Cellular and Molecula Biology, Dr. Chien-Tien Hsu’ Award for Outstanding Dissertation
- 2008 National Cheng Kung University, Excellent Research Award
Research Interests
- Neuroprotection
- Brain cancer stem cell
- Drug addiction
Related Link
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Jian-Ying Chuang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 8 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
探討膠質母細胞瘤腫瘤生態系統並開發新穎治療策略－MIF對TAN的調節作用介導了T細胞的抑制和GBM的異質性(2/3)
Chuang, J.-Y. (PI)
8/1/26 → 7/31/27
Project: A - Government Institution › b - National Science and Technology Council
-
評估神經類固醇代謝恢復和粒線體壓力緩解策略對創傷性腦損傷的治療潛力(2/3)
Chuang, J.-Y. (PI)
8/1/26 → 7/31/27
Project: A - Government Institution › b - National Science and Technology Council
-
新穎性藥物CLK4抑制劑應用於腦癌治療之研究
Chuang, J.-Y. (PI)
7/1/26 → 2/28/27
Project: A - Government Institution › b - National Science and Technology Council
-
Evaluating the Therapeutic Potential of Neurosteroid Metabolic Recovery and Mitochondrial Stress Relief Strategies in Traumatic Brain Injury
Chuang, J.-Y. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Role of Mif in Regulating the Tan-Mediated T Cell Suppression and Gbm Heterogeneity( I )
Chuang, J.-Y. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
KDM1A/HDAC2-driven epigenetic dysregulation maintains a drug-resistant, relapse-initiating glioblastoma cell niche at the peri-tumoral margin
Wu, A. C., Chuang, J. Y., Liu, J. J., Salim, E. A., Wu, M. H., Jing, S. W., Hsu, T. I., Chang, K. Y., Chang, W. C., Thakur, A., Liou, J. P. & Lo, W. L., Dec 2026, In: Biochemical Pharmacology. 254, 118415.Research output: Contribution to journal › Article › peer-review
Open Access -
Oxytocin mediates self–other and inevitability asymmetries in high-conflict moral judgment in schizophrenia
Cheng, M. H., Goh, K. K., Lu, M. L., Wang, C. H., Chuang, J. Y., Chen, C. & Yang, C. T., Jul 2026, In: Asian Journal of Psychiatry. 121, 105015.Research output: Contribution to journal › Article › peer-review
Open Access -
Proteasome Assembly Chaperone 3 Defines Metabolic-Immune Programs and Poor Prognosis in Breast Cancer via Multi-Omics Approaches
Kumar, S., Ta, H. D. K., Yang, H. C., Shih, C. L., Solomon, D. D., Ko, C. C., Xuan, D. T. M., Lee, Y. K., Chang, K. F., Lin, H. R., Kao, S. H., Chuang, J. Y., Chen, J. B., Wang, C. Y. & Nguyen, N. U. N., 2026, In: Journal of Cancer. 17, 3, p. 583-603 21 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Single-cell transcriptomics reveal PRRC1 as a malignant cell enriched driver of DNA repair and therapy resistance in glioblastoma
Kumar, S., Tsai, M. C., Solomon, D. D., Ngadio, J. L., Xuan, D. T. M., Ko, C. C., Lin, H. Y., Yen, M. C., Yeh, I. J., Lee, Y. K., Lin, H. R., Chuang, J. Y., Wang, C. Y. & Nguyen, N. U. N., May 2026, In: DNA Repair. 161, 103934.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Citation (Scopus) -
A novel dual CDC25-HDAC inhibitor suppresses glioblastoma progression via chromosomal passenger complex disruption
Upadhyay, R., Sethy, B., Yang, W. B., Wu, M. H., Liou, K. C., Wu, A. C., Narwanti, I., Nepali, K., Liou, J. P. & Chuang, J. Y., Dec 2025, In: Biomedicine and Pharmacotherapy. 193, 118816.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Citations (Scopus)
Datasets
-
MOESM7 of Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Chou, S.-W. (Creator), Chen, P.-Y. (Contributor), Chu, J.-M. (Contributor), Chien, C.-H. (Contributor), Liu, J.-J. (Creator), Liu, M.-S. (Creator), Chuang, J.-Y. (Creator), Chung, P.-H. (Contributor), Hsu, T.-I. (Contributor), Chen, S.-H. (Contributor), Yang, S.-T. (Creator), Lo, W.-L. (Creator), Huang, C.-Y. (Contributor), Chang, K.-Y. (Contributor), Yang, K.-Y. (Creator) & Yang, W.-B. (Creator), Figshare, 2019
DOI: 10.6084/m9.figshare.10006880.v1, https://doi.org/10.6084%2Fm9.figshare.10006880.v1
Dataset
-
MOESM2 of Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Chen, P.-Y. (Contributor), Yang, W.-B. (Creator), Chou, S.-W. (Creator), Yang, S.-T. (Creator), Chung, P.-H. (Contributor), Chang, K.-Y. (Contributor), Liu, M.-S. (Creator), Chen, S.-H. (Contributor), Chien, C.-H. (Contributor), Hsu, T.-I. (Contributor), Chu, J.-M. (Contributor), Huang, C.-Y. (Contributor), Yang, K.-Y. (Creator), Liu, J.-J. (Creator), Chuang, J.-Y. (Creator) & Lo, W.-L. (Creator), Figshare, 2019
DOI: 10.6084/m9.figshare.10006850.v1, https://doi.org/10.6084%2Fm9.figshare.10006850.v1
Dataset
-
Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Chien, C.-H. (Contributor), Chuang, J.-Y. (Creator), Yang, S.-T. (Creator), Yang, W.-B. (Creator), Chen, P.-Y. (Contributor), Hsu, T.-I. (Contributor), Huang, C.-Y. (Contributor), Lo, W.-L. (Creator), Yang, K.-Y. (Creator), Liu, M.-S. (Creator), Chu, J.-M. (Contributor), Chung, P.-H. (Contributor), Liu, J.-J. (Creator), Chou, S.-W. (Creator), Chen, S.-H. (Contributor) & Chang, K.-Y. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.c.4705370.v1, https://doi.org/10.6084%2Fm9.figshare.c.4705370.v1
Dataset
-
MOESM8 of Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Chung, P.-H. (Contributor), Chen, S.-H. (Contributor), Hsu, T.-I. (Contributor), Liu, M.-S. (Creator), Lo, W.-L. (Creator), Chu, J.-M. (Contributor), Yang, K.-Y. (Creator), Yang, S.-T. (Creator), Liu, J.-J. (Creator), Chuang, J.-Y. (Creator), Yang, W.-B. (Creator), Huang, C.-Y. (Contributor), Chien, C.-H. (Contributor), Chang, K.-Y. (Contributor), Chen, P.-Y. (Contributor) & Chou, S.-W. (Creator), Figshare, 2019
DOI: 10.6084/m9.figshare.10006883.v1, https://doi.org/10.6084%2Fm9.figshare.10006883.v1
Dataset
-
MOESM3 of Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Liu, J.-J. (Creator), Hsu, T.-I. (Contributor), Chou, S.-W. (Creator), Chuang, J.-Y. (Creator), Yang, W.-B. (Creator), Chen, P.-Y. (Contributor), Chen, S.-H. (Contributor), Yang, S.-T. (Creator), Chu, J.-M. (Contributor), Huang, C.-Y. (Contributor), Yang, K.-Y. (Creator), Chien, C.-H. (Contributor), Chung, P.-H. (Contributor), Lo, W.-L. (Creator), Liu, M.-S. (Creator) & Chang, K.-Y. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.10006856.v1, https://doi.org/10.6084%2Fm9.figshare.10006856.v1
Dataset